… Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after …
benefit most from it, future prospective randomized trials are urgently needed in this rapidly …

… Extracorporeal photopheresis (ECP) is an increasingly … GVHD are rare, and randomized
controlled trials (RCTs) are … their first allo-HSCT, randomized as 76 to the intervention group and …

… While there is no established second line GvHD-treatment, extracorporeal photophoresis
(… to lack of randomized controlled trials (RCT). We therefore conducted a RCT to study if ECP …

… randomized controlled trial, we found that a 12-week course of extracorporeal photopheresis
… -label crossover ECP study in 29 eligible participants randomized initially to the standard of …

… We undertook a prospective randomized controlled trial of extracorporeal photopheresis to
evaluate the effects of ECP treatment on the cutaneous and extracutaneous manifestations of …

… This figure was originally published in Blood, Volume 112: Flowers et al, A multicenter
prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic …

… After the first investigational study on the use of extracorporeal photopheresis for the treatment
of cutaneous T‐cell lymphoma was published in 1983 with its subsequent recognition by …

… studied by a great number of institutions, that there is a need for controlled randomized trials
in order to attain conclusive results about the beneficial effects of this treatment. Controlled …

… For the future, we suggest the initiation of a prospective randomized clinical study examining
correlations between the cellular content of leukapheresates harvested with different cell …

… 2 randomized study of extracorporeal photopheresis for treatment of chronic graftversus-host
disease. Blood 2008;112:2667–2674. 37 Costanzo-Nordin MR, Hubbell EA, O’Sullivan EJ, …